Mesa Short Long Term Debt Total from 2010 to 2024
| MLAB Stock | USD 118.35 1.90 1.63% |
Short and Long Term Debt Total | First Reported 1989-06-30 | Previous Quarter 145.6 M | Current Value 222.9 M | Quarterly Volatility 83.2 M |
Check Mesa Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mesa Laboratories' main balance sheet or income statement drivers, such as Interest Expense of 6 M, Total Revenue of 227 M or Gross Profit of 139.9 M, as well as many indicators such as Price To Sales Ratio of 2.94, Dividend Yield of 0.0054 or PTB Ratio of 2.35. Mesa financial statements analysis is a perfect complement when working with Mesa Laboratories Valuation or Volatility modules.
Mesa | Short Long Term Debt Total |
Latest Mesa Laboratories' Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of Mesa Laboratories over the last few years. It is Mesa Laboratories' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mesa Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
Mesa Short Long Term Debt Total Regression Statistics
| Arithmetic Mean | 92,653,390 | |
| Geometric Mean | 37,652,305 | |
| Coefficient Of Variation | 98.86 | |
| Mean Deviation | 81,811,001 | |
| Median | 46,260,000 | |
| Standard Deviation | 91,599,330 | |
| Sample Variance | 8390.4T | |
| Range | 242.4M | |
| R-Value | 0.93 | |
| Mean Square Error | 1286.5T | |
| R-Squared | 0.86 | |
| Slope | 18,968,125 | |
| Total Sum of Squares | 117466.1T |
Mesa Short Long Term Debt Total History
About Mesa Laboratories Financial Statements
Mesa Laboratories stakeholders use historical fundamental indicators, such as Mesa Laboratories' Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Mesa Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mesa Laboratories' assets and liabilities are reflected in the revenues and expenses on Mesa Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mesa Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 231.3 M | 242.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out the analysis of Mesa Laboratories Correlation against competitors. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (45.62) | Revenue Per Share 42.3 | Quarterly Revenue Growth 0.088 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.